Nuvation Bio INC. 8-K Filing
Ticker: NUVB · Form: 8-K · Filed: Nov 26, 2025 · CIK: 1811063
Sentiment: neutral
Filing Stats: 735 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2025-11-26 08:34:14
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value per share NUVB The New Yo
- $11.50 — of Common Stock at an exercise price of $11.50 per share NUVB.WS The New York Stoc
- $100 — or NUV-1511, which included a projected $100-150 million in R&D and CMC-related cost
Filing Documents
- d82457d8k.htm (8-K) — 30KB
- d82457dex991.htm (EX-99.1) — 52KB
- g82457ex99_1s10g1.jpg (GRAPHIC) — 83KB
- g82457ex99_1s11g1.jpg (GRAPHIC) — 107KB
- g82457ex99_1s12g1.jpg (GRAPHIC) — 108KB
- g82457ex99_1s13g1.jpg (GRAPHIC) — 99KB
- g82457ex99_1s14g1.jpg (GRAPHIC) — 152KB
- g82457ex99_1s15g1.jpg (GRAPHIC) — 90KB
- g82457ex99_1s16g1.jpg (GRAPHIC) — 116KB
- g82457ex99_1s17g1.jpg (GRAPHIC) — 125KB
- g82457ex99_1s18g1.jpg (GRAPHIC) — 136KB
- g82457ex99_1s19g1.jpg (GRAPHIC) — 116KB
- g82457ex99_1s1g1.jpg (GRAPHIC) — 50KB
- g82457ex99_1s20g1.jpg (GRAPHIC) — 97KB
- g82457ex99_1s21g1.jpg (GRAPHIC) — 46KB
- g82457ex99_1s22g1.jpg (GRAPHIC) — 128KB
- g82457ex99_1s23g1.jpg (GRAPHIC) — 116KB
- g82457ex99_1s24g1.jpg (GRAPHIC) — 88KB
- g82457ex99_1s25g1.jpg (GRAPHIC) — 122KB
- g82457ex99_1s26g1.jpg (GRAPHIC) — 121KB
- g82457ex99_1s27g1.jpg (GRAPHIC) — 74KB
- g82457ex99_1s28g1.jpg (GRAPHIC) — 81KB
- g82457ex99_1s29g1.jpg (GRAPHIC) — 155KB
- g82457ex99_1s2g1.jpg (GRAPHIC) — 190KB
- g82457ex99_1s30g1.jpg (GRAPHIC) — 48KB
- g82457ex99_1s31g1.jpg (GRAPHIC) — 119KB
- g82457ex99_1s32g1.jpg (GRAPHIC) — 44KB
- g82457ex99_1s33g1.jpg (GRAPHIC) — 87KB
- g82457ex99_1s34g1.jpg (GRAPHIC) — 63KB
- g82457ex99_1s35g1.jpg (GRAPHIC) — 125KB
- g82457ex99_1s36g1.jpg (GRAPHIC) — 133KB
- g82457ex99_1s3g1.jpg (GRAPHIC) — 121KB
- g82457ex99_1s4g1.jpg (GRAPHIC) — 96KB
- g82457ex99_1s5g1.jpg (GRAPHIC) — 44KB
- g82457ex99_1s6g1.jpg (GRAPHIC) — 60KB
- g82457ex99_1s7g1.jpg (GRAPHIC) — 91KB
- g82457ex99_1s8g1.jpg (GRAPHIC) — 113KB
- g82457ex99_1s9g1.jpg (GRAPHIC) — 95KB
- 0001193125-25-298551.txt ( ) — 5265KB
- nuvb-20251126.xsd (EX-101.SCH) — 4KB
- nuvb-20251126_def.xml (EX-101.DEF) — 14KB
- nuvb-20251126_lab.xml (EX-101.LAB) — 23KB
- nuvb-20251126_pre.xml (EX-101.PRE) — 15KB
- d82457d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Corporate Presentation of Nuvation Bio Inc. (November 26, 2025) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUVATION BIO INC. Date: November 26, 2025 By: /s/ Philippe Sauvage Name: Philippe Sauvage Title: Chief Financial Officer